⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Josep Carreras Leukaemia Research Institute (IJC) and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
The Josep Carreras Leukaemia Research Institute (IJC) is a premier European non-profit research center established in 2010 by the Government of Catalonia and the Josep Carreras Private Foundation. It is exclusively devoted to the study of leukemia and other malignant blood diseases, focusing on basic, epidemiological, preventive, clinical, and translational research.
The institute operates as a CERCA centre of excellence and is accredited as a Severo Ochoa Centre of Excellence. It integrates specialized research groups, a translational research program, and a Computational Diagnosis Centre that utilizes artificial intelligence to advance diagnostic and therapeutic approaches for hematological cancers.
CLASSIFICATION
SIZE & FINANCIALS
Employees:201-500
Founded:2010
Ownership:nonprofit
Status:operating
FUNDING
Investors:Government of Catalonia, Josep Carreras Private Foundation
PIPELINE
Stage:Discovery
Lead Drug Stage:Preclinical
Modalities:Cell therapy, Immunotherapy, Small molecule
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Subsidiaries:Leukos Biotech, OneChain Immunotherapeutics
Key Partnerships:AOP Health (Licensing/Collaboration), Cytognos S.L. (Diagnostic development)
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Ari Melnick - Director
LINKS
Website:carrerasresearch.org
Crunchbase:Crunchbase Profile
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Josep Carreras Leukaemia Research Institute (IJC). The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.